A high efficiency imager for real-time lung cancer monitoring during radiotherapy
用于放射治疗过程中实时肺癌监测的高效成像仪
基本信息
- 批准号:8917151
- 负责人:
- 金额:$ 76.06万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-09-01 至 2019-08-31
- 项目状态:已结题
- 来源:
- 关键词:AnatomyCancer PatientClinicClinicalCollaborationsComputer softwareDana-Farber Cancer InstituteDataDevelopmentDoseEnsureEyeFiberGeometryGoalsHealthImageImaging DeviceImaging TechniquesIntensity-Modulated RadiotherapyInternetLungLung NeoplasmsMalignant neoplasm of lungMarketingMeasurementMedicalMethodsModelingMonitorMotionNatureNoiseOnline SystemsPatientsRadiationRadiation therapyRecording of previous eventsResearchResearch PersonnelRespirationSystemTestingTimeTranslationsValidationWorkbasecancer imagingclinical applicationcostdesignimaging modalityimprovedmeetingsnovelphoton-counting detectorpre-clinicalresearch clinical testingresearch studytooltumor
项目摘要
DESCRIPTION (provided by applicant): Direct in-treatment imaging of lung tumors during radiation therapy to ensure proper radiation targeting is an unsolved challenge. We propose to overcome this obstacle using beam's-eye-view (BEV) imaging with a high efficiency imager to automatically localize lung tumors in real-time. The project goal is to design, validate and clinically deploy the new high efficiency imager. We will first determine the specifications necessary for robust BEV imaging. The design of the novel imager to meet this goal will be performed using a new Monte Carlo platform. Scintillator composition, pixelation and stacking of multiple layers will be optimized and the new imager will be validated prior to full scale deployment in a radiation therapy clinic. In addition to the immediate clinical benefits of real-tie lung tumor localization, we anticipate that this project will accelerate advanced applications like
tumor tracking, delivered dose accumulation and adaptive radiation therapy. The Monte Carlo platform will also hasten the development of novel imagers for other medical applications beyond this project. Therefore the impact of the project extends far beyond the immediate clinical gain, which is in itself substantial.
描述(由申请人提供):在放射治疗期间对肺肿瘤进行直接治疗中成像以确保适当的放射靶向是一项尚未解决的挑战。我们建议克服这一障碍,使用光束的眼睛视图(BEV)成像与高效率的成像自动定位实时肺肿瘤。该项目的目标是设计、验证和临床部署新型高效成像仪。我们将首先确定强大的BEV成像所需的规格。新的成像器的设计,以满足这一目标将使用一个新的蒙特卡罗平台。闪烁体成分、像素和多层堆叠将得到优化,新成像仪将在放射治疗诊所全面部署之前得到验证。除了实时肺部肿瘤定位的直接临床益处外,我们预计该项目将加速高级应用,如
肿瘤跟踪、递送剂量累积和适应性放射治疗。蒙特卡洛平台还将加速开发用于该项目以外的其他医疗应用的新型成像仪。因此,该项目的影响远远超出了直接的临床收益,这本身就是巨大的。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ross I. Berbeco其他文献
RETRACTED ARTICLE: Selective Priming of Tumor Blood Vessels by Radiation Therapy Enhances Nanodrug Delivery
撤回文章:放疗对肿瘤血管的选择性启动增强纳米药物递送
- DOI:
10.1038/s41598-019-50538-w - 发表时间:
2019-11-01 - 期刊:
- 影响因子:3.900
- 作者:
Sijumon Kunjachan;Shady Kotb;Robert Pola;Michal Pechar;Rajiv Kumar;Bijay Singh;Felix Gremse;Reza Taleeli;Florian Trichard;Vincent Motto-Ros;Lucie Sancey;Alexandre Detappe;Sayeda Yasmin-Karim;Andrea Protti;Ilanchezhian Shanmugam;Thomas Ireland;Tomas Etrych;Srinivas Sridhar;Olivier Tillement;Mike Makrigiorgos;Ross I. Berbeco - 通讯作者:
Ross I. Berbeco
Ross I. Berbeco的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ross I. Berbeco', 18)}}的其他基金
Translation of a Bismuth-Gadolinium Nanoparticle for MR-guided Radiation Therapy
用于 MR 引导放射治疗的铋钆纳米颗粒的转化
- 批准号:
10359706 - 财政年份:2020
- 资助金额:
$ 76.06万 - 项目类别:
Translation of a Bismuth-Gadolinium Nanoparticle for MR-guided Radiation Therapy
用于 MR 引导放射治疗的铋钆纳米颗粒的转化
- 批准号:
10626724 - 财政年份:2020
- 资助金额:
$ 76.06万 - 项目类别:
Gold nanoparticles as vascular disruptig agents in radiation therapy of NSCLC
金纳米粒子作为血管破坏剂在非小细胞肺癌放射治疗中的应用
- 批准号:
9026582 - 财政年份:2015
- 资助金额:
$ 76.06万 - 项目类别:
Gold nanoparticles as vascular disruptig agents in radiation therapy of NSCLC
金纳米粒子作为血管破坏剂在非小细胞肺癌放射治疗中的应用
- 批准号:
8893262 - 财政年份:2015
- 资助金额:
$ 76.06万 - 项目类别:
A novel flat-panel detector for advanced on-board radiation therapy imaging
用于先进机载放射治疗成像的新型平板探测器
- 批准号:
10652362 - 财政年份:2014
- 资助金额:
$ 76.06万 - 项目类别:
A high efficiency imager for real-time lung cancer monitoring during radiotherapy
用于放射治疗过程中实时肺癌监测的高效成像仪
- 批准号:
9318469 - 财政年份:2014
- 资助金额:
$ 76.06万 - 项目类别:
A novel flat-panel detector for advanced on-board radiation therapy imaging
用于先进机载放射治疗成像的新型平板探测器
- 批准号:
10202493 - 财政年份:2014
- 资助金额:
$ 76.06万 - 项目类别:
A high efficiency imager for real-time lung cancer monitoring during radiotherapy
用于放射治疗过程中实时肺癌监测的高效成像仪
- 批准号:
9358862 - 财政年份:2014
- 资助金额:
$ 76.06万 - 项目类别:
A novel flat-panel detector for advanced on-board radiation therapy imaging
用于先进机载放射治疗成像的新型平板探测器
- 批准号:
10428566 - 财政年份:2014
- 资助金额:
$ 76.06万 - 项目类别:
相似海外基金
Research Project 2 Proteogenomic-guided therapeutic targeting of breast cancer patient-derived xenograft metastases
研究项目 2 蛋白质基因组引导的乳腺癌患者异种移植转移的治疗靶向
- 批准号:
10733315 - 财政年份:2023
- 资助金额:
$ 76.06万 - 项目类别:
SQLE and Sterols Contribute to Racial Disparity in ER+ Breast Cancer Patient Survival
SQLE 和甾醇导致 ER 乳腺癌患者生存率的种族差异
- 批准号:
10571020 - 财政年份:2023
- 资助金额:
$ 76.06万 - 项目类别:
Establishing industrial production of components that enable expanding accessibility of PET imaging to cancer patient population.
建立组件的工业化生产,使癌症患者群体能够更容易地获得 PET 成像。
- 批准号:
10698218 - 财政年份:2023
- 资助金额:
$ 76.06万 - 项目类别:
Washington University PDX Development and Trial Center - Evaluation of Abemaciclib in Combination with Olaparib in Ovarian Cancer and Breast Cancer Patient-derived Xenograft Models
华盛顿大学 PDX 开发和试验中心 - Abemaciclib 联合 Olaparib 在卵巢癌和乳腺癌患者异种移植模型中的评估
- 批准号:
10582164 - 财政年份:2022
- 资助金额:
$ 76.06万 - 项目类别:
Towards Cancer Patient Empowerment for Optimal Use of Antithrombotic Therapy at the End of Life
增强癌症患者在临终时最佳使用抗血栓治疗的能力
- 批准号:
10039823 - 财政年份:2022
- 资助金额:
$ 76.06万 - 项目类别:
EU-Funded
Convening a gynecologic cancer patient advisory group to adapt a digital health tool
召集妇科癌症患者咨询小组以采用数字健康工具
- 批准号:
460767 - 财政年份:2022
- 资助金额:
$ 76.06万 - 项目类别:
Miscellaneous Programs
Towards Cancer Patient Empowerment for Optimal Use of Antithrombotic Therapy at the End of Life
增强癌症患者在临终时最佳使用抗血栓治疗的能力
- 批准号:
10038000 - 财政年份:2022
- 资助金额:
$ 76.06万 - 项目类别:
EU-Funded
Longitudinal mixed method investigation of social networks and affective states as determinants of smoking behavior among cancer patient
社会网络和情感状态作为癌症患者吸烟行为决定因素的纵向混合方法调查
- 批准号:
10513670 - 财政年份:2021
- 资助金额:
$ 76.06万 - 项目类别:
Improving the translational value of head and neck cancer patient-in-mouse models
提高头颈癌小鼠模型的转化价值
- 批准号:
10598311 - 财政年份:2021
- 资助金额:
$ 76.06万 - 项目类别:
Improving the translational value of head and neck cancer patient-in-mouse models
提高头颈癌小鼠模型的转化价值
- 批准号:
10442585 - 财政年份:2021
- 资助金额:
$ 76.06万 - 项目类别: